Loading…
The significance of the prepubertal diabetes duration for the development of retinopathy and nephropathy in patients with type 1 diabetes
Objective: A Danish nationwide prospective cohort of children and adolescents with type 1 diabetes was followed for 8 years to study the effect of the prepubertal duration of diabetes on early retinopathy and elevated albumin excretion rate (AER) (>20 μg/min). Research Design and Methods: In 1989...
Saved in:
Published in: | Journal of diabetes and its complications 2004-05, Vol.18 (3), p.160-164 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Objective: A Danish nationwide prospective cohort of children and adolescents with type 1 diabetes was followed for 8 years to study the effect of the prepubertal duration of diabetes on early retinopathy and elevated albumin excretion rate (AER) (>20 μg/min). Research Design and Methods: In 1989, blood glucose control (HbA1c) and AER was investigated in approximately 80% of all Danish children and adolescents with type 1 diabetes. A cohort of 339 young patients were restudied in 1995 including physical examination, demographic data, HbA1c, AER, and fundus photography with central reading. Among the patients, a number of 304 had a prepubertal onset of diabetes defined as an onset age less than 11.7 years in girls and 12.9 years in boys. Microalbuminuria was defined as an AER of 20–150 μg min−1 and macroalbuminuria as AER >150 μg min−1 in two out of three timed overnight urine samples. Results: At the follow-up in 1995–1996, no patients were younger than 12 years of age. The prevalence of any level of retinopathy was 17.7% in the age group 12–15 years, 45.4% from 16 to 20 years, and increased to 67.6% in patients more than 20 years of age. Diabetic retinopathy was significantly associated to poor long-term metabolic control (HbA1c) (P |
---|---|
ISSN: | 1056-8727 1873-460X |
DOI: | 10.1016/S1056-8727(03)00073-4 |